With the growing emphasis on respiratory wellness and early intervention for sleep disorders, the UK CPAP market is poised to ...

ResMed's first-quarter result broadly met market expectations, though rising margins and potential for further capital ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has shared an update. ResMed Inc.’s Chief Financial Officer, ...

ResMed Inc. closed 16.14% below its 52-week high of $293.81, which the company reached on August 22nd.

Tariffs on medical devices would push up prices and disrupt research and development efforts at the expense of US patients, ...

Using different oximeter devices for monitoring stable patients under NIV or CPAP may have an unpredictable effect on results and clinical decisions.

An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc. has filed its ...

Resmed is making another strategic investment in U.S.-based manufacturing and distribution, this time in Indianapolis. The move aims to position the company’s inventory of CPAP devices ...

Key opportunities in the UK sleep apnea devices market include leveraging rising demand for efficient healthcare, expanding AI and ML integration for personalized care, and catering to an aging, ...

The United States Continuous Positive Airway Pressure (CPAP) market is on a steady growth trajectory, expected to reach USD 4 ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal first-quarter net income of $348.5 million. On a per-share basis, the San Diego-based company said it had net income of ...

Pacific Sleep Apnea Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...